NCT07191587View on ClinicalTrials.gov

A Controlled Clinical Trial Assessing the Efficacy of Vitamin B Prophylaxis in Attenuating Paclitaxel-induced Neuropathy and the Imperative Use of Gabapentin in Diabetic Ovarian Cancer Patients and the Potential Effect on Disease Response.

NACompletedINTERVENTIONAL

Enrollment

146

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

May 30, 2025

Conditions

Peripheral Neuropathy, Chemotherapy-inducedDisease Management

Interventions

DIETARY_SUPPLEMENT

Vitamin B Complex

Vitamin B complex given as prophylaxis in prophylactic arm and as treatment in non-prophylactic arm.

Trial Locations (1)

11796

National Cancer Institute, Cairo

All Listed Sponsors

lead

National Cancer Institute, Egypt

OTHER

NCT07191587 - A Controlled Clinical Trial Assessing the Efficacy of Vitamin B Prophylaxis in Attenuating Paclitaxel-induced Neuropathy and the Imperative Use of Gabapentin in Diabetic Ovarian Cancer Patients and the Potential Effect on Disease Response. | Biotech Hunter | Biotech Hunter